<?xml version="1.0" encoding="UTF-8"?>
<p id="Par43">In one study, ribavarin 200Â mg twice daily for 1 week was tried on ten patients with chronic CHIK compared to placebo, with some effect [
 <xref ref-type="bibr" rid="CR41">41</xref>]. Other promising molecules reported to have some efficacy in CHIK are bindarit [
 <xref ref-type="bibr" rid="CR42">42</xref>], an inhibitor of monocyte chemoattractant protein-1 (MCP-1), inhibitors targeting the mannose-binding lectin (MBL) pathway of the complement system [
 <xref ref-type="bibr" rid="CR43">43</xref>] and beclin, which is an autophagy-inducing peptide [
 <xref ref-type="bibr" rid="CR44">44</xref>]. Other potential drugs with anti-CHIK action are niclosamide, nitazoxanide and suramin, all of which inhibit virus entry, fusion, binding and cell-to-cell transmission [
 <xref ref-type="bibr" rid="CR45">45</xref>, 
 <xref ref-type="bibr" rid="CR46">46</xref>].
</p>
